Qualitative study of blister pack use during buprenorphine low dose initiation
- 5 May 2026
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (4) , 103130
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (2K24DA042720)
- Agency for Healthcare Research and Quality (K12HS026383)
This publication has 30 references indexed in Scilit:
- Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold SettingJAMA Network Open, 2025
- Outpatient Low-Dose Initiation of Buprenorphine for People Using FentanylJAMA Network Open, 2025
- Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using FentanylJAMA Network Open, 2024
- Evaluating a novel pharmacist‐led buprenorphine outreach service for treatment of opioid use disorder in individuals residing in supportive housingJACCP: Journal of the American College of Clinical Pharmacy, 2024
- Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid EnrolleesJAMA Network Open, 2023
- High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use DisorderJAMA Network Open, 2021
- Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine InductionClinical Drug Investigation, 2021
- The Pharmacology of Buprenorphine Microinduction for Opioid Use DisorderClinical Drug Investigation, 2021
- Patients’ experiences with multidose drug dispensing: a cross sectional studyInternational Journal of Clinical Pharmacy, 2018
- The experiences and beliefs of older people in Scottish very sheltered housing about using multi-compartment compliance aidsInternational Journal of Clinical Pharmacy, 2018